Global Strategic Management’s GSK GSK Stock Holding History

Global Strategic Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$500K	Buy	+10,872	New	+$499K	0.59%	28

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Global Strategic Management's GSK Position: Q4 2020 in Review

Global Strategic Management opened a new position in GSK (GSK) in Q4 2020: 10,872 shares worth $500K. The stake represents 0.59% of the portfolio and ranks #28 among its holdings.

819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Global Strategic Management held 10,872 shares of GSK worth $500K as of Q4 2020.
GSK was a new Global Strategic Management position in Q4 2020.
GSK made up 0.59% of Global Strategic Management's portfolio in Q4 2020, its #28 holding.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Global Strategic Management's 13F filing for Q4 2020, filed 10 Feb 2021.